Combination Therapy Seen to Slow Further Spread of Metastatic Breast Cancer in Clinical Trial
News
In women with ERBB2-positive metastatic breast cancer, the combination treatment of neratinib-paclitaxel may help to delay and reduce metastases in the central nervous system compared to trastuzumab-paclitaxel. The study, “Neratinib Plus ... Read more